In honor of Equal Pay Day, PEOPLE has the exclusive first trailer for 'Lilly,' starring Patricia Clarkson Sharareh Drury is a writer on the Movies team at PEOPLE. She joined PEOPLE in 2025 and has ...

In this article, we are going to take a look at where Kohl’s Corporation (NYSE:KSS) stands against other stocks that Jim Cramer talked about. On Friday, Jim Cramer, the host of Mad Money ...

Lily Stewart ended up back in handcuffs — and with another glamorous mugshot — anyway. The University of Georgia student, is facing a second round of charges, this time for obstruction of a ...

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/ ...

Others get a tattoo, book a trip, maybe start journaling. Lily Allen? She got a boob job. On the Thursday, March 20 episode of her Miss Me? podcast, the 39-year-old British singer opened up about ...

Eli Lilly and Company (NYSE: LLY) today announced that preclinical data for agents targeting SMARCA2 (BRM) and multiple KRAS mutations will be presented at the American Association for Cancer ...

Eli Lilly (LLY) will soon be releasing trial data on its small-molecule GLP-1 weight-loss pill, Orforglipron. The drug could be pivotal for the obesity treatment market due to its accessibility.

**NM signifies a non meaningful value. A dash signifies the data is not available.

Eli Lilly has said it is prepared to invest £279 million ($364 million) in the UK and work with the government to tackle serious public health challenges, including obesity. The proposal ...

The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli Lilly's diabetes and obesity drug tirzepatide. The US ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...